Congenital Adrenal Hyperplasia (CAH)

Overview and management of CAH.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
EndocrinologyPaediatrics

Clinical Guidelines

NICE guideline [NG243]: Adrenal insufficiency: identification and management
National
NICE guideline [NG243]: Primary adrenal insufficiency, Congenital adrenal hyperplasia (CAH), Secondary and tertiary adrenal insufficiency
National
Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline
Local
Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline
Local
EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency
Local
Initial management and stabilisation of the newborn infant with a positive screen for congenital adrenal hyperplasia (CAH): An ANZSPED guideline
Local